Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU clears Guidant's Multi-Link Frontier bifurcation stent:

This article was originally published in Clinica

Executive Summary

Guidant Multi-Link Frontier stent system treats plaque in coronary arteries at the site of a bifurcation, where one vessel branches from another. The Multi-Link Frontier coronary bifurcation stent is designed to help overcome the problem of blocking blood flow to a side vessel, a concern associated when using traditional stents. It incorporates a novel side-branch portal that allows physicians to preserve access to the side branch. Some 20% of patients treated for coronary artery disease have lesions at bifurcations. The product will be made available in Europe, Australia and New Zealand immediately, and will soon be expanded to countries in Asia and the Middle East.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts